Sickle Cell Disease (SCD) is a significant public health concern in the GCC countries, with prevalence rates ranging from 0.24% to 5.8%
New hope for a once neglected disease: Pfizer highlights the essential approach to raise awareness about Sickle Cell Disease and reveals SHAPE survey key findings in Gulf
To further highlight its commitment on improving patient outcomes in the Gulf, Pfizer hosted a media roundtable to raise awareness on Sickle Cell Disease (SCD) and revealed key findings from Sickle Cell Health Awareness, Perspectives, and Experiences (SHAPE) Survey conducted in several countries including GCC. Attended by leading healthcare professionals, the roundtable was designed to share valuable insights on patient experiences, psychosocial burdens, and the impact of SCD on the quality of life of patients and caregivers.
Continue reading Pfizer highlights the essential approach to raise awareness about Sickle Cell Disease and reveals SHAPE survey key findings in Gulf
UAE News 24/7 